vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.
SPS COMMERCE INC is the larger business by last-quarter revenue ($192.7M vs $123.8M, roughly 1.6× NATURES SUNSHINE PRODUCTS INC). SPS COMMERCE INC runs the higher net margin — 13.4% vs 3.3%, a 10.1% gap on every dollar of revenue. On growth, SPS COMMERCE INC posted the faster year-over-year revenue change (12.7% vs 4.7%). SPS COMMERCE INC produced more free cash flow last quarter ($38.2M vs $7.6M). Over the past eight quarters, SPS COMMERCE INC's revenue compounded faster (13.5% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
NATR vs SPSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $192.7M |
| Net Profit | $4.1M | $25.8M |
| Gross Margin | 72.5% | 70.4% |
| Operating Margin | 4.3% | 18.0% |
| Net Margin | 3.3% | 13.4% |
| Revenue YoY | 4.7% | 12.7% |
| Net Profit YoY | 1379.4% | 47.2% |
| EPS (diluted) | $0.23 | $0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $192.7M | ||
| Q3 25 | $128.3M | $189.9M | ||
| Q2 25 | $114.8M | $187.4M | ||
| Q1 25 | $113.2M | $181.5M | ||
| Q4 24 | $118.2M | $170.9M | ||
| Q3 24 | $114.6M | $163.7M | ||
| Q2 24 | $110.6M | $153.6M | ||
| Q1 24 | $111.0M | $149.6M |
| Q4 25 | $4.1M | $25.8M | ||
| Q3 25 | $5.3M | $25.6M | ||
| Q2 25 | $5.3M | $19.7M | ||
| Q1 25 | $4.7M | $22.2M | ||
| Q4 24 | $-321.0K | $17.6M | ||
| Q3 24 | $4.3M | $23.5M | ||
| Q2 24 | $1.3M | $18.0M | ||
| Q1 24 | $2.3M | $18.0M |
| Q4 25 | 72.5% | 70.4% | ||
| Q3 25 | 73.3% | 69.5% | ||
| Q2 25 | 71.7% | 68.1% | ||
| Q1 25 | 72.1% | 68.7% | ||
| Q4 24 | 72.0% | 67.5% | ||
| Q3 24 | 71.3% | 68.5% | ||
| Q2 24 | 71.4% | 66.1% | ||
| Q1 24 | 71.2% | 65.6% |
| Q4 25 | 4.3% | 18.0% | ||
| Q3 25 | 7.0% | 16.4% | ||
| Q2 25 | 3.7% | 14.1% | ||
| Q1 25 | 5.4% | 14.3% | ||
| Q4 24 | 3.8% | 14.5% | ||
| Q3 24 | 4.6% | 15.6% | ||
| Q2 24 | 5.1% | 15.1% | ||
| Q1 24 | 4.2% | 10.3% |
| Q4 25 | 3.3% | 13.4% | ||
| Q3 25 | 4.2% | 13.5% | ||
| Q2 25 | 4.6% | 10.5% | ||
| Q1 25 | 4.2% | 12.2% | ||
| Q4 24 | -0.3% | 10.3% | ||
| Q3 24 | 3.8% | 14.3% | ||
| Q2 24 | 1.2% | 11.7% | ||
| Q1 24 | 2.1% | 12.0% |
| Q4 25 | $0.23 | $0.69 | ||
| Q3 25 | $0.30 | $0.67 | ||
| Q2 25 | $0.28 | $0.52 | ||
| Q1 25 | $0.25 | $0.58 | ||
| Q4 24 | $-0.02 | $0.46 | ||
| Q3 24 | $0.23 | $0.62 | ||
| Q2 24 | $0.07 | $0.48 | ||
| Q1 24 | $0.12 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $151.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $973.9M |
| Total Assets | $261.1M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $151.4M | ||
| Q3 25 | $95.6M | $133.7M | ||
| Q2 25 | $81.3M | $107.6M | ||
| Q1 25 | $86.5M | $94.9M | ||
| Q4 24 | $84.7M | $241.0M | ||
| Q3 24 | $78.7M | $205.8M | ||
| Q2 24 | $68.7M | $271.8M | ||
| Q1 24 | $77.8M | $290.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $973.9M | ||
| Q3 25 | $166.7M | $958.9M | ||
| Q2 25 | $163.7M | $949.8M | ||
| Q1 25 | $167.1M | $920.9M | ||
| Q4 24 | $161.0M | $854.7M | ||
| Q3 24 | $162.6M | $829.4M | ||
| Q2 24 | $156.4M | $703.4M | ||
| Q1 24 | $159.7M | $683.0M |
| Q4 25 | $261.1M | $1.2B | ||
| Q3 25 | $264.8M | $1.2B | ||
| Q2 25 | $254.9M | $1.1B | ||
| Q1 25 | $252.7M | $1.1B | ||
| Q4 24 | $240.9M | $1.0B | ||
| Q3 24 | $245.3M | $1.0B | ||
| Q2 24 | $235.8M | $854.5M | ||
| Q1 24 | $247.3M | $839.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $45.9M |
| Free Cash FlowOCF − Capex | $7.6M | $38.2M |
| FCF MarginFCF / Revenue | 6.1% | 19.8% |
| Capex IntensityCapex / Revenue | 1.9% | 4.0% |
| Cash ConversionOCF / Net Profit | 2.41× | 1.78× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $152.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $45.9M | ||
| Q3 25 | $18.5M | $60.6M | ||
| Q2 25 | $4.3M | $32.3M | ||
| Q1 25 | $2.6M | $40.0M | ||
| Q4 24 | $12.2M | $40.6M | ||
| Q3 24 | $9.6M | $53.3M | ||
| Q2 24 | $1.3M | $29.4M | ||
| Q1 24 | $2.2M | $34.1M |
| Q4 25 | $7.6M | $38.2M | ||
| Q3 25 | $16.8M | $54.6M | ||
| Q2 25 | $3.0M | $25.7M | ||
| Q1 25 | $1.5M | $33.8M | ||
| Q4 24 | $10.0M | $34.3M | ||
| Q3 24 | $7.9M | $48.1M | ||
| Q2 24 | $-2.0M | $24.4M | ||
| Q1 24 | $-1.5M | $30.5M |
| Q4 25 | 6.1% | 19.8% | ||
| Q3 25 | 13.1% | 28.7% | ||
| Q2 25 | 2.6% | 13.7% | ||
| Q1 25 | 1.3% | 18.6% | ||
| Q4 24 | 8.5% | 20.1% | ||
| Q3 24 | 6.9% | 29.4% | ||
| Q2 24 | -1.9% | 15.9% | ||
| Q1 24 | -1.4% | 20.4% |
| Q4 25 | 1.9% | 4.0% | ||
| Q3 25 | 1.3% | 3.2% | ||
| Q2 25 | 1.2% | 3.6% | ||
| Q1 25 | 1.0% | 3.4% | ||
| Q4 24 | 1.9% | 3.6% | ||
| Q3 24 | 1.5% | 3.2% | ||
| Q2 24 | 3.0% | 3.3% | ||
| Q1 24 | 3.3% | 2.4% |
| Q4 25 | 2.41× | 1.78× | ||
| Q3 25 | 3.46× | 2.37× | ||
| Q2 25 | 0.81× | 1.64× | ||
| Q1 25 | 0.55× | 1.80× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | 2.21× | 2.27× | ||
| Q2 24 | 0.97× | 1.63× | ||
| Q1 24 | 0.94× | 1.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
SPSC
| Recurring Revenues | $184.5M | 96% |
| One Time Revenues | $8.1M | 4% |
| Set Up Fees | $4.1M | 2% |
